ROLE OF C5A IN INFLAMMATORY RESPONSES
Top Cited Papers
- 1 April 2005
- journal article
- review article
- Published by Annual Reviews in Annual Review of Immunology
- Vol. 23 (1) , 821-852
- https://doi.org/10.1146/annurev.immunol.23.021704.115835
Abstract
▪ Abstract The complement system not only represents an effective innate immune mechanism of host defense to eradicate microbial pathogens, but it is also widely involved in many forms of acute and chronic inflammatory diseases including sepsis, acute lung injury, ischemia-reperfusion injury, and asthma, to give just a few examples. The complement-activated product, C5a, displays powerful biological activities that lead to inflammatory sequelae. C5a is a strong chemoattractant and is involved in the recruitment of inflammatory cells such as neutrophils, eosinophils, monocytes, and T lymphocytes, in activation of phagocytic cells and release of granule-based enzymes and generation of oxidants, all of which may contribute to innate immune functions or tissue damage. Accumulating data suggest that C5a provides a vital bridge between innate and adaptive immune functions, extending the roles of C5a in inflammation. Herein, we review human and animal data describing the cellular and molecular mechanisms of C5a in the development of inflammatory disorders, sepsis, acute lung injury, ischemia-reperfusion injury, and asthma.Keywords
This publication has 149 references indexed in Scilit:
- The anaphylatoxins bridge innate and adaptive immune responses in allergic asthmaMolecular Immunology, 2004
- Neutrophil C5a receptor and the outcome in a rat model of sepsisThe FASEB Journal, 2003
- Early Circulating Lymphocyte Apoptosis in Human Septic Shock Is Associated with Poor OutcomeShock, 2002
- C5a receptor and thymocyte apoptosis in sepsisThe FASEB Journal, 2002
- C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathwayKidney International, 2002
- A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticariaJournal of Allergy and Clinical Immunology, 2002
- Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunctionThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Effects of anti‐C5a monoclonal antibodies on oxygen use in a porcine model of severe sgifisEuropean Journal of Clinical Investigation, 1998
- The interleukin-8-receptor family: from chemokines to malariaImmunology Today, 1994
- The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculaturein vitro andin vivoInflammation Research, 1991